Early detection of prostate cancer has led to a reduction in the number of men with metastatic cancer over time, researchers found in a population-based study analyzing patients in the U.S. and Denmark. The study findings were presented at the European Association of Urology Congress 2018 (EAU2018) in Copenhagen, Denmark, in a lecture titled “Incidence and survival trends of de-novo metastatic prostate cancer - a population-based analysis of two national cohorts from USA and Denmark”. The team analyzed metastatic prostate cancer incidence in two large groups of patients from the U.S. and Denmark: 29,555 men registered at the Surveillance, Epidemiology and End Results (SEER), and diagnosed from 1980 to 2011, and 6,874 men included in the Danish Prostate Cancer Registry (DaPCaR), and diagnosed from 1995 to 2011. Patients were grouped according to the time they were diagnosed, and each group was analyzed separately and compared to the others. In the SEER group, the largest and longest one, the incidence of metastatic prostate cancer dropped from 12.0 cases per 100,000 men from 1980 to 1984, to 4.4 cases per 100,000 men from 2005 to 2011.